Leap Therapeutics Historical PE Ratio image   This LPTX PE ratio history page last updated 3/21/2024
Leap Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/18/2024
2.14-0.46-1.84NA
Q3 2023
11/13/2023
1.43-0.51-2.04NA
Q2 2023
8/14/2023
2.40-0.91-3.64NA
Q1 2023
5/15/2023
4.50-3.20-12.80NA
Q4 2022
3/24/2023
3.18-1.10-4.40NA
Q3 2022
11/14/2022
7.05-1.30-5.20NA
Q2 2022
8/12/2022
12.90-1.50-6.00NA
Q1 2022
5/13/2022
13.10-0.90-3.60NA
Q4 2021
3/11/2022
17.40-1.00-4.00NA
Q3 2021
11/12/2021
24.60-1.40-5.60NA
Q2 2021
8/13/2021
16.80-1.20-4.80NA
Q1 2021
5/14/2021
15.70-1.20-4.80NA
Q4 2020
3/12/2021
23.90-0.90-3.60NA
Q3 2020
11/12/2020
15.40-0.90-3.60NA
Q2 2020
8/13/2020
19.10-1.20-4.80NA
Q1 2020
5/14/2020
22.00-5.50-22.00NA
Q4 2019
3/16/2020
13.00-3.20-12.80NA
Q3 2019
11/14/2019
6.27-3.30-13.20NA
Q2 2019
8/9/2019
15.50-3.70-14.80NA
Q1 2019
5/15/2019
15.40-4.70-18.80NA
Q4 2018
4/1/2019
19.50-3.50-14.00NA
Q3 2018
11/9/2018
41.60-5.50-22.00NA
Q2 2018
8/8/2018
65.90-5.00-20.00NA
Q1 2018
5/11/2018
74.20-8.50-34.00NA
Q4 2017
2/23/2018
65.90-6.50-26.00NA
Q3 2017
11/13/2017
62.50-7.30-29.20NA
Leap Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/18/2024
2.14-0.46-5.08NA
Q3 2023
11/13/2023
1.43-0.51-5.72NA
Q2 2023
8/14/2023
2.40-0.91-6.51NA
Q1 2023
5/15/2023
4.50-3.20-7.10NA
Q4 2022
3/24/2023
3.18-1.10-4.80NA
Q3 2022
11/14/2022
7.05-1.30-4.70NA
Q2 2022
8/12/2022
12.90-1.50-4.80NA
Q1 2022
5/13/2022
13.10-0.90-4.50NA
Q4 2021
3/11/2022
17.40-1.00-4.80NA
Q3 2021
11/12/2021
24.60-1.40-4.70NA
Q2 2021
8/13/2021
16.80-1.20-4.20NA
Q1 2021
5/14/2021
15.70-1.20-4.20NA
Q4 2020
3/12/2021
23.90-0.90-8.50NA
Q3 2020
11/12/2020
15.40-0.90-10.80NA
Q2 2020
8/13/2020
19.10-1.20-13.20NA
Q1 2020
5/14/2020
22.00-5.50-15.70NA
Q4 2019
3/16/2020
13.00-3.20-14.90NA
Q3 2019
11/14/2019
6.27-3.30-15.20NA
Q2 2019
8/9/2019
15.50-3.70-17.40NA
Q1 2019
5/15/2019
15.40-4.70-18.70NA
Q4 2018
4/1/2019
19.50-3.50-22.50NA
Q3 2018
11/9/2018
41.60-5.50-25.50NA
Q2 2018
8/8/2018
65.90-5.00-27.30NA
Q1 2018
5/11/2018
74.20-8.50NANA
Q4 2017
2/23/2018
65.90-6.50NANA
Q3 2017
11/13/2017
62.50-7.30NANA
Quotes delayed 20 minutes

Email EnvelopeFree LPTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Leap Therapeutics (LPTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LQDA PE Ratio History
LRMR PE Ratio History
LTRN PE Ratio History
LUCD PE Ratio History
LUMO PE Ratio History
LUNG PE Ratio History
LXEO PE Ratio History
LXRX PE Ratio History
LYEL PE Ratio History
LYRA PE Ratio History
How should the LPTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Leap Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LPTX Historical PE Ratio page.

What is the average historical PE for LPTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LPTX historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for LPTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LPTX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Leap Therapeutics Historical PE Ratio information for Leap Therapeutics' stock. The average LPTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LPTX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LPTX historical PE result, against the recent PE: when this page was posted on 3/20/2024, the most recent closing price for LPTX had been 2.55, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on LPTX or any other given stock, valuation analysis for LPTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Leap Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LPTX. Thanks for visiting, and the next time you need to research LPTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of EIP, TMX Videos, Funds Holding GLAQ.

 

Leap Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.